226 related articles for article (PubMed ID: 30805678)
1. Extensive undertreatment of osteoporosis in older Swedish women.
Lorentzon M; Nilsson AG; Johansson H; Kanis JA; Mellström D; Sundh D
Osteoporos Int; 2019 Jun; 30(6):1297-1305. PubMed ID: 30805678
[TBL] [Abstract][Full Text] [Related]
2. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
Leslie WD; Martineau P; Bryanton M; Lix LM
Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
[TBL] [Abstract][Full Text] [Related]
3. Low-energy distal radius fractures in middle-aged and elderly men and women--the burden of osteoporosis and fracture risk : A study of 1794 consecutive patients.
Øyen J; Gjesdal CG; Brudvik C; Hove LM; Apalset EM; Gulseth HC; Haugeberg G
Osteoporos Int; 2010 Jul; 21(7):1257-67. PubMed ID: 19813045
[TBL] [Abstract][Full Text] [Related]
4. Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway.
Hoff M; Skurtveit S; Meyer HE; Langhammer A; Søgaard AJ; Syversen U; Skovlund E; Abrahamsen B; Forsmo S; Schei B
Osteoporos Int; 2018 Aug; 29(8):1875-1885. PubMed ID: 29774403
[TBL] [Abstract][Full Text] [Related]
5. The potential impact of new National Osteoporosis Foundation guidance on treatment patterns.
Dawson-Hughes B; Looker AC; Tosteson AN; Johansson H; Kanis JA; Melton LJ
Osteoporos Int; 2010 Jan; 21(1):41-52. PubMed ID: 19705046
[TBL] [Abstract][Full Text] [Related]
6. Bone health-related factors and the use of bisphosphonates in community setting--15-year follow-up study.
Sirola J; Salovaara K; Rikkonen T; Kärkkäinen M; Tuppurainen M; Jurvelin JS; Honkanen R; Kröger H
Osteoporos Int; 2011 Jan; 22(1):255-64. PubMed ID: 20422155
[TBL] [Abstract][Full Text] [Related]
7. Bone material strength is associated with areal BMD but not with prevalent fractures in older women.
Rudäng R; Zoulakis M; Sundh D; Brisby H; Diez-Perez A; Johansson L; Mellström D; Darelid A; Lorentzon M
Osteoporos Int; 2016 Apr; 27(4):1585-1592. PubMed ID: 26630975
[TBL] [Abstract][Full Text] [Related]
8. Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA.
Wilk A; Sajjan S; Modi A; Fan CP; Mavros P
Osteoporos Int; 2014 Dec; 25(12):2777-86. PubMed ID: 25112720
[TBL] [Abstract][Full Text] [Related]
9. Automated DXA-based finite element analysis for hip fracture risk stratification: a cross-sectional study.
Yang S; Leslie WD; Luo Y; Goertzen AL; Ahmed S; Ward LM; Delubac I; Lix LM
Osteoporos Int; 2018 Jan; 29(1):191-200. PubMed ID: 29038836
[TBL] [Abstract][Full Text] [Related]
10. Is lower income associated with an increased likelihood of qualification for treatment for osteoporosis in Canadian women?
Brennan SL; Leslie WD; Lix LM
Osteoporos Int; 2014 Jan; 25(1):273-9. PubMed ID: 23907573
[TBL] [Abstract][Full Text] [Related]
11. The proportion of Thai postmenopausal women who would be eligible for anti-osteoporosis therapy.
Chanidkul P; Sribenjalak D; Charoenngam N; Pongchaiyakul C
PLoS One; 2023; 18(2):e0279829. PubMed ID: 36735672
[TBL] [Abstract][Full Text] [Related]
12. FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK.
McCloskey E; Kanis JA; Johansson H; Harvey N; Odén A; Cooper A; Cooper C; Francis RM; Reid DM; Marsh D; Selby P; Thompson F; Hewitt S; Compston J
Osteoporos Int; 2015 Aug; 26(8):2091-9. PubMed ID: 26077380
[TBL] [Abstract][Full Text] [Related]
13. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group.
Siris ES; Adler R; Bilezikian J; Bolognese M; Dawson-Hughes B; Favus MJ; Harris ST; Jan de Beur SM; Khosla S; Lane NE; Lindsay R; Nana AD; Orwoll ES; Saag K; Silverman S; Watts NB
Osteoporos Int; 2014 May; 25(5):1439-43. PubMed ID: 24577348
[TBL] [Abstract][Full Text] [Related]
14. Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study.
Berry SD; Kiel DP; Donaldson MG; Cummings SR; Kanis JA; Johansson H; Samelson EJ
Osteoporos Int; 2010 Jan; 21(1):53-60. PubMed ID: 19937426
[TBL] [Abstract][Full Text] [Related]
15. Use of a performance algorithm improves utilization of vertebral fracture assessment in clinical practice.
Schousboe J; McKiernan F; Fuehrer J; Binkley N
Osteoporos Int; 2014 Mar; 25(3):965-72. PubMed ID: 24121999
[TBL] [Abstract][Full Text] [Related]
16. Gender differences for initiating teriparatide therapy: baseline data from the Direct Assessment of Nonvertebral Fracture in the Community Experience (DANCE) study.
Wong M; Wan X; Ruff V; Krohn K; Taylor K
Osteoporos Int; 2012 Apr; 23(4):1445-52. PubMed ID: 21769662
[TBL] [Abstract][Full Text] [Related]
17. Preoperative bone health assessment and optimization in spine surgery.
Anderson PA; Kadri A; Hare KJ; Binkley N
Neurosurg Focus; 2020 Aug; 49(2):E2. PubMed ID: 32738805
[TBL] [Abstract][Full Text] [Related]
18. Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years.
Ferrari S; Adachi JD; Lippuner K; Zapalowski C; Miller PD; Reginster JY; Törring O; Kendler DL; Daizadeh NS; Wang A; O'Malley CD; Wagman RB; Libanati C; Lewiecki EM
Osteoporos Int; 2015 Dec; 26(12):2763-71. PubMed ID: 26068295
[TBL] [Abstract][Full Text] [Related]
19. The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005-2008.
Dawson-Hughes B; Looker AC; Tosteson AN; Johansson H; Kanis JA; Melton LJ
Osteoporos Int; 2012 Mar; 23(3):811-20. PubMed ID: 21717247
[TBL] [Abstract][Full Text] [Related]
20. A before-and-after study of fracture risk reporting and osteoporosis treatment initiation.
Leslie WD; Morin S; Lix LM
Ann Intern Med; 2010 Nov; 153(9):580-6. PubMed ID: 21041577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
